Adeline Sillaire-Rollin

Lille, 59000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study.

Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study.

Journal: Revue neurologique
Published: December 29, 2025

Diagnosis of Alzheimer's disease: Recommendations from the French Federation of Memory Clinics.

Diagnosis of Alzheimer's disease: Recommendations from the French Federation of Memory Clinics.

Journal: Revue neurologique
Published: May 14, 2025

Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer disease.

Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer disease.

Journal: Alzheimer's research & therapy
Published: November 18, 2024

Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.

Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: July 11, 2023

Quantitative susceptibility mapping demonstrates different patterns of iron overload in subtypes of early-onset Alzheimer's disease.

Quantitative susceptibility mapping demonstrates different patterns of iron overload in subtypes of early-onset Alzheimer's disease.

Journal: European radiology
Published: April 06, 2022

A multimodal, longitudinal study of cognitive heterogeneity in early-onset Alzheimer's disease.

A multimodal, longitudinal study of cognitive heterogeneity in early-onset Alzheimer's disease.

Journal: European journal of neurology
Published: January 28, 2021

Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 Years.

Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 Years.

Journal: Journal of Alzheimer's disease : JAD
Published: August 06, 2019

The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease.

The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease.

Journal: European journal of nuclear medicine and molecular imaging
Published: April 12, 2018

Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.

Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.

Journal: Neurobiology of aging
Published: May 22, 2017

18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer's disease.

18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer's disease.

Journal: Neurobiology of aging
Published: April 03, 2017

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.

Journal: PLoS medicine
Published: September 08, 2016

17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression.

17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression.

Journal: Molecular psychiatry
Published: July 20, 2016
Showing 1-12 of 22

Last Updated: 09/26/2026